You are here:

MS in the media

12 October 2018
Cannabis Plant
  • Medicinal cannabis decision
  • Licence application for SPMS drug
  • Depression in MS
Read more

05 October 2018
Stem cells
  • Annual flu vaccination launched in Scotland
  • Stem cell therapy improved fatigue
Read more

28 September 2018
Person holding a cigarette
  • Smoking worsens MS
  • Gilenya for younger people
  • Social networks influence health
  • Ten years of the Risk-sharing Scheme
Read more

14 September 2018
Scientist conducting research
  • Ocrevus turned down for PPMS
  • Ocrevus slows progression
  • Prevalence of benign MS
  • Statins trial starts in SPMS
  • Gilenya effective in childhood MS
Read more

31 August 2018
Woman in green dress sleeping on sofa
  • Ibudilast slows atrophy in progressive MS
  • Sleep affects MS symptoms
  • Tecfidera and Gilenya compared
  • Managing functional illness
Read more

17 August 2018
  • New mum diagnosed with MS
  • Rare genetic changes linked to primary progressive MS
  • Early termination of pregnancy increases risk of relapses
Read more

10 August 2018
  • Congratulations to Trishna Bharadia
  • Smoking and relapses
  • Travelling with disabilities
  • Long delays for neurologist appointments in Northern Ireland
  • Botox for bladder problems
Read more

20 July 2018
Cannabis plant
  • Doctors should be allowed to prescribe medical cannabis
  • Early warning signs of MS
  • Iron levels in brain may predict future disability
Read more

06 July 2018
Air pollution - smoke coming out of factories near river
  • Ocrelizumab not approved for PPMS
  • Solvents, smoking and MS risk
  • Air pollutants not linked to MS
  • Cannabis review finds benefits
Read more

22 June 2018
stress
  • NICE say yes to Ocrevus for RRMS
  • Review of medical cannabis
  • PIP review changes
  • Tysabri in SPMS
  • Stress linked to MS risk
Read more

15 June 2018
Family standing together outdoors
  • School project explores MS
  • Tecfidera and Gilenya compared
  • Ocrevus delays progression
  • Ocrevus in PPMS - new trial announced
  • Obesity and smoking and risk of MS
  • Family support helps
Read more

18 May 2018
stethoscope
  • NICE approves injectable drugs for relapsing MS
  • Gilenya approved for young Americans
  • AAN meeting round up
  • RCN supports medical cannabis
  • Vitamins and dietary supplements
Read more

11 May 2018
Caring holding hands
  • Social care crisis
  • Managing fatigue online
  • Spinal fluid test for risk of progression
Read more

20 April 2018
Cognition
  • Plan to extend personal health budgets
  • Ocrevus (ocrelizumab) a year on
  • Differences in cognition for people with SPMS
Read more

13 April 2018
Housing
  • Lemtrada and possible new side effects
  • Tysabri study in SPMS
  • Fighting for housing rights
  • Risk of infections when on DMDs
Read more

06 April 2018
Computer brain training
  • NICE says no to ocrelizumab for RRMS
  • Childbirth pain relief doesn't increase relapse risk
  • Cognitive training helps memory
  • Prescription charge increase
  • Flying with a disability
Read more

29 March 2018
Neurology
  • Scottish MPs told of neurology recruitment crisis
  • MS nurses criticise cumbersome disability benefits system
  • Fears that funding for independent living may be under threat
Read more

23 March 2018
Stem Cells graphic
  • Stem cell study for people with highly active relapsing MS shows promising results
  • Caroline Wyatt talks about stem cell treatment
  • Siponimod secondary progressive MS results published in Lancet
Read more

16 March 2018
Unhappy couple
  • Calnexin increases number of immune cells crossing blood-brain barrier
  • My wife has MS and is no longer interested in any sexual contact
Read more

09 March 2018
Sunshine
  • Zinbryta withdrawn due to safety fears
  • Sunshine exposure reduces MS risk
  • Paralympian with MS
  • Unsuccessful trial of PPMS drug
Read more

02 March 2018
Oily Fish
  • Oily fish and risk of MS
  • EBV prevalence
  • Deaths associated with neurological conditions
  • Radio play about MS
Read more

23 February 2018
Scientist using microscope
  • Think Hand campaign launched
  • ACTRIMS conference review
  • The work of the MS Brain Bank
Read more

09 February 2018
Pregnancy
  • Encouraging stem cell results
  • Tysabri and reducing relapse risk in pregnancy
  • Stigma and depression
Read more

02 February 2018
Balance
  • Review of all PIP claims following ruling
  • Balance programme improved symptoms
Read more

26 January 2018
St John's Wort
  • Sativex available in Jersey
  • Drug and herbal remedy interactions
  • Urology clinic in Sheffield
Read more

19 January 2018
Cannabis Plant
  • FDA finds against vitamin D and risk of MS claim
  • Medical cannabis supported by Welsh Assembly
  • Branded vs generic glatiramer study
Read more

12 January 2018
Curling
  • First PPMS drug licensed
  • Comparison of disease modifying drugs
  • Paralympic curler with MS
  • Bad living conditions for people with MS in Glasgow
Read more

29 December 2017
Cartoon man holding DNA
  • The effect of MS on work - a teacher's story
  • MS and cancer
  • Chickenpox, shingles and MS
  • Mild cognitive impairment and exercise
  • Stem cell therapy
Read more

22 December 2017
Drugs
  • NICE recommends restricting choice of MS drugs
  • MS treatment optimism
  • Having MS and other conditions
  • Diagnostic criteria updated
Read more

15 December 2017
Man sitting on tree stump and holding his head
  • Gilenya and Betaferon compared
  • Pain prevalence and treatment
  • Cold water in the mouth helps heat sensitivity
  • Benefit reassessment concerns
  • Review of the year - MS in America
Read more

08 December 2017
Healthy diet
  • Diet may improve MS
  • Laquinimod trial for PPMS unsuccessful
  • Epilepsy and MS
  • Stem cell therapy consensus report
Read more

01 December 2017
T cell
  • Shortage of neurology services
  • Diet affects gut bacteria and modulates immune system
  • Cognitive symptoms in early-stage MS
  • High number of people with MS turned down for PIP
  • Biotin may affect medical tests
Read more

24 November 2017
Stem cells
  • Mark Lewis and stem cells
  • Self-management may help mood
  • CCSVI trial disappointing
  • Why smoking is bad for people with MS
Read more

17 November 2017
Wii console and remote
  • Ocrevus licensed for relapsing and progressive MS
  • Gilenya effective for children with MS
  • Social care failing people with disabilities
  • Wii a useful way to exercise
Read more

09 November 2017
ECTRIMS 2017 - picture of skyline of Paris

Reports of studies presented at the ECTRIMS meeting that took place from 25-28 October 2017.  Topics include research into existing and new drugs for relapsing and progressive MS and lifestyle factors in MS.

Read more

03 November 2017
heart with vital sign in the middle
  • Ibudilast trial show benefit in progressive MS
  • Gilenya effective as treatment for teens with MS
  • Zinbryta liver damage restrictions
  • Having other health conditions delays MS diagnosis
  • The benefits of running for a woman with MS
Read more

13 October 2017
Chips and ketchup dip
  • Fatty diet and relapse risk
  • Clemastine may help repair MS damage
  • The MS symptoms that contribute most to perception of health
Read more

06 October 2017
Salt shaker
  • Salt doesn't cause MS
  • Fatigue treated with small electric current
  • Taxi discrimination challenged
  • Stem cells - the genuine potential and the dodgy clinics
  • MS drugs in Northern Ireland
Read more

29 September 2017
Packets of drugs
  • Disease modifying drugs - early vs escalation trial
  • Moves to reclassify pregabalin and gabapentin
  • Links between cognition and mobility
  • Lemtrada remains effective over five years
  • Fall risk and bladder dysfunction
  • MS disease activity linked to depression and anxiety
Read more

22 September 2017
Person in a wheelchair
  • Stem cell therapy in the UK
  • Falls are common in wheelchair users
  • Cognitive fatigue and incentives
Read more

15 September 2017
cartoon gut and bacteria
  • Vitamin D levels and risk of MS
  • Concussions in adolescence raises MS risk
  • The possible role of bacteria in the gut in MS
  • Stem cell therapy review
  • Cognition in primary progressive MS
  • The benefits of work
  • Care for people in Scotland with a neurological condition
  • Benefits system criticised
Read more

08 September 2017
researcher carrying out research
  • Research into alternative therapies is poor
  • Cladribine (Mavenclad) use over four years
  • Fingolimod in children
  • Perceptions of MS in older people
Read more

01 September 2017
Virus
  • Benefits changes affecting people with MS
  • South Korean court sees MS as an occupational disease
  • Glandular fever and risk of MS
  • Self-management suggestions
  • Tecfidera after Tysabri
Read more

25 August 2017
Close-up image of a horse
  • Are we close to a cure?
  • Raising the profile of horse riding for the disabled
  • Cladribine (Mavenclad) gets European licence for highly active relapsing MS
Read more

18 August 2017
Soldiers walking
  • Armed forces at higher risk of dying from MS
  • Sticking with disease modifying drugs
  • Older MS drugs may be linked to increased cancer risk
  • Gut bacteria
  • Cladribine and quality of life
Read more

11 August 2017
Man walking with walking stick
  • Botulinum toxin treatment for spasticity
  • Jamie-Lynn Sigler on walking sticks
  • Addressing gaps in care for people with MS
  • Parenting with a disability
  • Jack Osbourne reflects on five years of living with MS
Read more

27 July 2017
Running track
  • Athlete with MS successful at Para Championship
  • Cannabis as treatment of last resort
Read more

21 July 2017
Brain
  • Access to disease modifying drugs
  • The cost of MS
  • Protecting cognitive reserve
  • Diet and childhood MS
  • Vitamin D and bone health
  • Depression risk factors
Read more

14 July 2017
breastfeeding image
  • EMA restricts use of Zinbryta
  • Kadeena Cox interview
  • Breastfeeding, menstruation and risk of MS
Read more

07 July 2017
Mental health
  • Small study of lipoic acid for SPMS
  • Living with hidden disabilities
  • Types of vitamin D
  • Stem cell tourism
  • Carers' mental health
  • Neurological conditions and mental health services
  • Access to MS treatments in Wales
  • Smell and progressive MS
Read more

30 June 2017
youtube
  • Cladribine recommended for European licence
  • Glastonbury in an all-terrain wheelchair
  • YouTube star behind Pixiwoo beauty empire reveals she has MS
  • Enjoying family life
  • TV wedding
Read more

23 June 2017
Smoking cigarette
  • Smoking and progressive MS
  • MRI scans and disability levels
  • Suicide risk measured
  • European vaccine ruling
  • Ocrelizumab and disease activity
Read more

16 June 2017
Swimming pool
  • Carers Week - the challenges of being a carer
  • Zinbryta and possible liver damage
  • Lemtrada side effect explained
  • Water rehabilitation
  • Sodium and MS onset
  • CMSC round up
Read more

09 June 2017
Television
  • Nano-particle treatment being developed
  • Statins and cognition
  • MS storylines in soaps
Read more

02 June 2017
Man and lady talking in coffee shop window
  • Lessons from a walking stick
  • Acne drug delays MS onset
  • Social cognition worse in MS
Read more

26 May 2017
Drugs
  • Biotin trial planned
  • Ozanimod trial results
  • Gilenya effect on relapses
  • Neurological Alliance manifesto
  • Fampridine granted full licence
  • Case of PML in Ocrevus
Read more

19 May 2017
Scales and measuring tape
  • Safety of beta interferon
  • Children, vitamin D and obesity
  • Weight and MS severity
  • Brain training and cognition
  • Assisted suicide rethink
  • Garden for MS
Read more

12 May 2017
contraceptive tablets
  • Statins for SPMS
  • Laquinimod trial unsuccessful
  • Clues to MS five years before onset
  • Vitamin D and birth month
  • Contraceptive safety in MS
  • Carers and the impact of MS
Read more

08 May 2017
AAN (Academy of American Neurologists) meeting 2017

Reports of studies presented at the American Academy of Neurology meeting that took place from 22-28 April 2017.  Reports include research into disease modifying drugs for relapsing MS and risk factors for MS.

Read more

20 April 2017
DNA double helix
  • Genes and MS risk
  • Tecfidera and NEDA
  • Early warnings of future MS diagnosis revealed in medical history
Read more

13 April 2017
  • Eating and MS
  • Life expectancy measured
  • Vehicle leasing affected by benefit changes
  • Lemtrada and listeria
Read more

31 March 2017
thumbs up
  • Ocrelizumab approved in US for relapsing and progressive MS
  • Kidney and bladder stone risk
  • ADHD in children of women with MS
Read more

24 March 2017
woman looking out of the window
  • Anxiety and the link to depression
  • Anxiety and psychosocial factors
  • Invisible disability toilet signs
  • Trigeminal neuralgia at onset of MS
Read more

17 March 2017
artistic brain image
  • Early treatment with disease modifying drugs
  • Contraceptives and relapses
  • Neurological services declining
  • Access to neurologists
  • Myelin repair research
  • Caroline Wyatt and stem cell therapy
  • Daclizumab (Zinbryta) approved in England and Wales
  • Delayed acceptance of NICE approved drugs
  • Prescription charge rises
Read more

10 March 2017
  • Surgery to open up narrowed veins not effective in MS 
  • Kadeena Cox on MS
  • Runner with MS sets herself 1000km challenge
Read more

03 March 2017
Horse
  • Caroline Wyatt and stem cell therapy
  • MS and dementia
  • Progression risk factors
  • Horses as therapy
Read more

24 February 2017
mobility scooter driving away
  • Stem cell study shows long-term benefits and risks
  • Cognition and electrical stimulation
  • Benefit changes
  • Access to Motability vehicles
Read more

17 February 2017
airport
  • Disease modifying drugs and clinically isolated syndrome
  • Fampridine response changes over time
  • Disability assistance at airports lacking
  • Disease modifying drugs compared
Read more

10 February 2017
doctor measuring the waist of a patient cartoon
  • Obesity and early puberty as MS risk factors
  • Cladribine and atrophy
  • Blood test for MS type
Read more

03 February 2017
Smiley faces depicting different emotions
  • Disease modifying drug comparison analysis
  • The long-term effects of disease modifying drugs
  • Uveitis and MS
  • Anxiety and cognition
  • Stem cell therapy five year results
  • Computer based cognitive rehab
Read more

20 January 2017
Happy man
  • Coping better with long-term conditions
  • Hollyoaks MS storyline
  • Tysabri and PML
  • Genes and risk of MS in families
  • Relapse risk when switching from Gilenya to Lemtrada
Read more

13 January 2017
vegetable basket
  • Mixed results for cyclophosphamide in SPMS
  • MS on TV
  • Paleo diet trial results
  • Review of evidence for cannabis
  • Review of research in 2016
Read more

06 January 2017
traffic
  • New Year's honours for people with MS
  • Lifestyle impact on MS
  • Living near busy roads
  • Magnetic stimulation and brain activity
  • Gilenya (fingolimod) in Wales
Read more

23 December 2016
the world
  • Falls and bladder problems
  • The World vs MS
  • Tysabri concentrations and PML
  • Ocrelizumab trial results published
  • Breath test for diagnosis
Read more

09 December 2016
racing car
  • Copaxone and pregnancy recommendations changed
  • Racing driver with MS
  • Disease modifying treatment in more advanced stage MS
Read more

02 December 2016
hard boiled eggs on avacado toast
  • Sports Personality of the Year shortlist published
  • Vitamin D and MS risk
  • What stem cell research says about progressive MS
  • Researching diet and MS
  • Emerging treatments for progressive MS
Read more

18 November 2016
ballet dancer on point
  • Course of later onset MS
  • Effect of fatigue and depression on sex
  • Ballet for ataxia
Read more

11 November 2016
person stretching their leg before exercise
  • Use of dietary approaches to manage MS
  • Brain tissue ratios and prognosis
  • Exercise is valuable for people with more advanced MS
  • Development of progressive MS research
Read more

04 November 2016
breast cancer awareness
  • Work capability assessment to be reviewed
  • Rituximab
  • MS and breast cancer
  • Fampridine
  • Living up north could speed up onset of MS
Read more

28 October 2016
abstract nerve fibres
  • ECTRIMS video highlights
  • MS in the modern treatment era
  • Biotin study results
  • Nerves that affect postural control
Read more

21 October 2016
family smiling on a beach
  • SNP backs decriminalising cannabis for medical use
  • More MS nurses needed in West Yorkshire
  • Tysabri (natalizumab) reduces depression in MS
  • MS Society survey finds "disturbing levels" of workplace bullying
  • Importance of family
Read more

14 October 2016
Stress
  • How people with MS feel about risk
  • Stress and onset of symptoms
  • Lemtrada (alemtuzumab) and disability improvement
  • Stress incontinence in women with MS
  • Factors indicating how MS may develop
  • Low dose naltrexone safety study
  • Intimate relations
Read more

07 October 2016
man sitting down and looking at the sea
  • ESA re-assessments
  • NICE turns down daclizumab
  • Mindfulness helps with coping
  • Tysabri vs Gilenya comparison
Read more

23 September 2016
ECTRIMS 2016 - picture of Tower Bridge in London

Reports of studies presented at the ECTRIMS meeting that took place from 14-17 September 2016.  Reports include research into disease modifying drugs for relapsing and progressive MS, stem cells and lifestyle factors in MS.

Read more

23 September 2016
man holding his own hand
  • MS at the Paralympics
  • Gene research for progressive MS questioned
  • Natural history of people on disease modifying drugs
  • MPs support call for medical cannabis
  • Film about footballer with MS released on DVD
  • Older people with MS
  • Ageing with MS
  • Progressive MS research funding
  • Guidelines on more than one long-term condition
  • ECTRIMS round up
Read more

09 September 2016
adult sitting alone
  • How heat affects people with MS
  • Paralympians with MS
  • Negative attitudes to people with MS
  • Tamoxifen may help myelin repair
  • Genes don't suggest course of MS
Read more

02 September 2016
person holding a camera
  • The effect of childhood MS on parents
  • Review of the medical understanding of childhood MS
  • Explaining MS
  • Please offer me a seat
  • How lifestyle factors affect MS
  • Photography project focuses on MS
  • Low white blood cell count and MS
Read more

26 August 2016
sunlight
  • Genes and vitamin D
  • Siponimod trial in secondary progressive MS
  • Amiselimod trial results
Read more

19 August 2016
blood pressure monitor
  • Wales lagging behind in access to treatment
  • High blood pressure may be associated with MS progression
  • Neurological Alliance report on neurology and primary care
  • Benefits changes and eligibility for Motability
  • Camping with MS
Read more

12 August 2016
patient in bed getting treated
  • Using mobility scooter for days out
  • New technique for stem cell transplants
  • Benefits of early treatment
Read more

05 August 2016
dog
  • Gut microbes and MS
  • Financial, personal and work related impact of MS
  • Relapses following second or subsequent pregnancies
  • TENS for MS spasticity
  • Poetry and MS
  • Assistance dog
  • Coping with life's changes
Read more

29 July 2016
Piggy bank
  • Disease modifying drugs may help people with "benign" MS
  • Stephanie Millward talks about the impact of MS
  • Stem cells
  • Anecdotal success and research evidence
  • Financial management with MS
  • Communicating prognosis
  • Disabled dressage rider asked to pay extra for using additional equipment
  • Study highlights progressive decline for people with MS

 

Read more

22 July 2016
magician causing cards to hover
  • Developing drugs for progressive MS
  • Magician on living with MS
  • Vitamin D recommendation for general population
Read more

08 July 2016
tape measure
  • Overweight people more likely to develop MS
  • Gut bacteria differ in people with MS
  • Integrated care transforms lives of disabled people
  • Lifestyle based approach to MS
  • Zinbryta (daclizumab) licensed
  • Effect of MS on carers
  • Cause of depression as MS symptom
Read more

24 June 2016
DNA
  • Commissioning community services
  • Progressive MS Alliance meeting
  • New genes associated with MS
  • Caroline Wyatt on her diagnosis
  • Rituximab
Read more

17 June 2016
girl sleeping in bed
  • Awareness of MS
  • Sleep and cognition
  • People affected by MS - Caroline Wyatt
  • People affected by MS - Stephanie Millward
  • Cerebral microbleeds
  • Vitamin D
Read more

10 June 2016
elderly couple holding hands
  • Older people with MS
  • Opicinumab (anti-lingo-1) trail disappointing
  • Stem cell trial shows long-term benefits
Read more

07 June 2016
Consortium of Multiple Sclerosis Centers MS in the media

Reports of studies presented at the CMSC (Consortium of Multiple Sclerosis Centers) meeting that took place from 1-4 June 2016.  Reports include research into  drugs for MS, better understanding of symptoms and lifestyle factors.

Read more

03 June 2016
golfing in the sunset
  • Fasting-mimicking diet studied
  • More proactive care for sexual dysfunction encouraged
  • Golfer with MS
  • Gene linked to rare form of MS
Read more

27 May 2016
man working at his desk
  • Vitamin D in Orkney
  • The effect of MS on employment
  • Invisible symptoms of MS
  • Young carers blog
  • Fasting-mimicking diet
  • A bicycle with MS
Read more

20 May 2016
virus particles
  • Neurological Alliance unhappy with government response to report
  • Relapses and disease modifying drugs
  • Progressive MS treatments review
  • Vitamin D levels in Orkney
  • Gut bacteria in children with MS
  • Viruses and onset of MS
  • Pregabalin and birth defects
  • Inequalities in multiple sclerosis care
  • Potential treatment for PML
Read more

13 May 2016
healthy food
  • Long-term use of disease modifying drugs
  • Symptoms during relapses and progression
  • The potential of ocrelizumab
  • AAN meeting round up
  • Diet and inflammation in the brain
  • Cancer risk and MS
  • Mitoxantrone and cancer risk
  • Carers and the Care Act
  • Palliative care services patchy
Read more

06 May 2016
yoga
  • Zinbryta (daclizumab) nears approval in Europe
  • Ocrelizumab and progressive MS
  • Too much sitting is bad for you
  • Yoga or aquatic exercise help MS symptoms
  • CCSVI symptoms not unique to MS
  • Gilenya (fingolimod) rebound risk
  • Suicide rates higher in MS
Read more

29 April 2016
girl using smartphone
  • Engaging with MS services
  • Vitamin D review
  • Tysabri and progression study
  • Review of current research
  • Monitoring MS with mobile devices
  • MS affects moral cognition
Read more

22 April 2016
American Academy of Neurology (AAN)

Reports of studies presented at the American Academy of Neurology meeting that took place from 15-21 April 2016.  Reports include researchinto disease modifying drugs for relapsing MS, approaches to repair of nerves and risk factors for MS.

Read more

15 April 2016
shark
  • Medical cannabis arguments
  • MS Therapy Centre visit
  • The interaction of pain, depression and fatigue
  • MS. A song cycle
  • Small trial hints at possibility of nerve repair
  • Identifying factors that increase MS risk
  • Footballer with MS
  • Punching sharks on the nose
Read more

08 April 2016
Paralympian
  • DMDs and brain atrophy
  • Do Paralympians encourage or deter exercise?
  • Beta interferon in children
  • Myelitis and MS
  • Most PIP appeals are successful
  • Switching to rituximab or Gilenya from Tysabri
  • The effect of other health conditions
Read more

01 April 2016
thumbs up
  • Rosacea and MS risk
  • Finding new life in wheelchair tennis
  • Holidaymakers needed
  • MS in families studied
  • Finding positives
Read more

24 March 2016
padlock
  • World Congress on Controversies in Neurology (CONy)
  • Benefit changes withdrawn
  • Gadolinium safety review
  • Ibudilast fast track status
Read more

18 March 2016
image of a calculator next to a notepad
  • The Budget and benefit changes
  • Beta interferon and pregnancy
  • Review of ACTRIMS neurology conference
  • MS in East London
Read more

11 March 2016
pregnant woman
  • Vitamin D in pregnancy
  • More than one autoimmune condition and progression risk
  • Small study of antidiabetic drugs
  • Brain training may improve thinking
  • Athlete with MS
  • MS and other health conditions

 

Read more

04 March 2016
cup of coffee
  • Recommendations for Tysabri and PML
  • Neurological services in Scotland
  • Pregnancy and risk of progression
  • Virtual reality and balance
  • Rituximab trial unsuccessful for SPMS
  • Coffee and risk of MS
Read more

26 February 2016
person rowing close up
  • Rowing from home
  • Delays in MS services
  • Lessons for fingolimod for progressive MS trial
  • Neurological services criticised
  • Medicinal cannabis campaign
Read more

19 February 2016
cartoon holding magnifying glass
  • EMA guidance on PML
  • Ocrelizumab approval process in the US
  • Ozanimod trial results
  • Disease modifying drugs and progression
  • Investigating the effect of other conditions on MS
Read more

12 February 2016
pile of cigarettes
  • Vitamin D and onset of MS
  • Measuring disease activity
  • Gender differences in MS
  • Trial to predict how MS will develop
  • Woman with MS on bed blocking
  • Sense of taste
  • Smoking and nicotine
  • Christian Jessen's MS connection
  • Campaign launched to legalise medicinal cannabis
Read more

05 February 2016
computer
  • Fingolimod for PPMS trial unsuccessful
  • Arthritis treatment and MS risk
  • The difficulty of claiming benefits
  • Step training study
  • Company pulls out of female hormone treatment
  • Work and MS
  • Tysabri v fingolimod
  • Indicators of risk of primary progressive MS
Read more

29 January 2016
young girl
  • Phenytoin trial results
  • Risk of relapse when switching treatment
  • Stem cell therapy review
  • Tysabri and risk of PML
  • Young carer
Read more

22 January 2016
Cells
  • Stem cells therapy on Panorama
  • Respite services in Edinburgh
  • The potential of stem cells
  • Oestrogen supplement trial results
  • Consultation on further changes to benefits
Read more

31 December 2015
person operating laptop
  • NHS choir
  • Fampridine and walking speed
  • Work and MS symptoms
  • Talking to children about MS
  • Vitamin D study
Read more

24 December 2015
adult brainstorm
  • Success rate in MS drug trials
  • Review of the year
  • Biggest 'game changer' of 2015
  • Care home ratings
  • Stem cell therapy
Read more

18 December 2015
Brain cells
  • Brain cell death and nanoparticles
  • Making the most of your life with MS in 2016 and beyond
  • Sense of smell
  • Woman dies after ruling to stop feeding
Read more

11 December 2015
  • Vitamin D and myelin production
  • Rehabilitation research reviewed
  • John Kurtzke
  • National MS Society review of research 2015
Read more

04 December 2015
Christmas
  • Songs about MS
  • Oestrogen supplement trial results
  • Biotin and optic neuritis
  • Coping with Christmas
  • Disability and society
Read more

26 November 2015
Artist painting
  • Social care crisis
  • Artists with MS
  • Spending Review
  • Reporting medically unfit drivers
Read more

20 November 2015
Chocolate
  • Tecfidera and PML
  • Chocolate and fatigue
  • The impact of benefit changes
  • End of life judgement
Read more

13 November 2015
Cancer
  • Drug repurposing bill runs out of time
  • Diet and MS - Association of UK Dietitians policy statement
  • Vitamin D and atrophy
  • Cancer drug fund in Wales
Read more

30 October 2015
Measuring fitness

24-30 October 2015

  • EMA guidance on Tecfidera
  • People affected by MS - Dave Myers
  • Photographs of MS
  • HIV drug for MS
  • Accurately measuring fitness
  • Drug repurposing bill
Read more

23 October 2015
image of money
  • Tysabri trial for SPMS is negative
  • ECTRIMS round up
  • The cost of MS
  • Athlete with MS
Read more

15 October 2015
cartoon image of a brain
  • ECTRIMS reports
  • Aubagio and brain tissue loss
  • Generic version of glatiramer acetate is effective
Read more

09 October 2015
Man holding unhappy sign in front of his face
  • Ocrelizumab effective in all types of MS
  • Daclizumab study results
  • Gilenya (fingolimod) long-term benefits
  • Aubagio (teriflunomide) real world study
  • Sativex in clinical practice
  • Stopping smoking reduces brain atrophy
  • Suicide and self harm risks higher in MS
Read more

08 October 2015
Sun
  • Tecfidera (dimethyl fumarate) follow up
  • Lemtrada (alemtuzumab) five year follow up
  • Tysabri (natalizumab) longer dosing
  • Gilenya (fingolimod) shows no benefit in primary progressive MS
  • Vitamin D levels and race
  • Sun exposure and low weight delay MS onset
  • Stem cell communication
Read more

07 October 2015
Trophy
  • Woman of the Year award for woman with MS
  • Aubagio and atrophy
  • New MS centre in Stoke
Read more

30 September 2015
Man running next to mountain and sea view
  • Early treatment urged for relapsing MS
  • Dalfampridine for vision
  • Living with MS
  • Athlete with MS
Read more

25 September 2015
Olympic rings
  • Olympic hopeful with MS
  • Potential PML vaccine being developed
  • Measuring progression in trials
Read more

23 September 2015
Lady standing away from camera with her arms stretched
  • NICE social care guidelines published
  • New progressive MS research grants
  • Disease modifying drugs review
  • What affects quality of life in MS?
Read more